Document is current
Any future updates will be listed below
-
Authors
Lombardi Fäh, Valeria https://orcid.org/0000-0002-1621-6653
Catarino, Rosa
Castillo, Sarah
Badda, Maria
Gezer-Dickschat, Sibel
Thieringer, Friederike
Tschudin, Sibil
Viviano, Manuela
Yaron, Michal
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05174195 at ClinicalTrials.govDocuments that mention this clinical trial
Can a 3 months treatment with oral Desogestrel prior to insertion of the etonogestrel-releasing contraceptive implant improve continuation rate at 1 year? A randomized trial
https://doi.org/10.1186/s13104-023-06304-3
-
Funding
Funding for this research was provided by:
Merck and Cie Schaffhausen
- License Information
-
More Information
Article History
Received: 10 July 2022
Accepted: 2 March 2023
First Online: 13 March 2023
Declarations
:
: Approved by the Ethics Committee of Geneva on 12.04.2017 (CCER 2016-00972).The trial was retrospectively registered on with the ID NCT05174195, the 30th December 2021. The manuscript adheres to CONSORT guidelines. All patients signed an informed consent prior to recruitment.
: All the authors have approved the manuscript for publication.
: There are no disclosures of interest regarding financial, personal, intellectual, or religious interests. Completed disclosure of interests are available to view online as supporting information.
